Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATryn in preterm preeclampsia
NCT02059135Phase 3Completed
- Sponsor
- rEVO Biologics
- Start
- Jul 2014
- Primary completion
- May 2016
- Countries
- 1
01
Overview
A Phase 3 trial of antithrombin III in preeclampsia, sponsored by rEVO Biologics. Started Jul 2014; status: completed.
02
Drugs
antithrombin III
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT02059135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02059135.